No Clear Winner in Trial of Tests for Low-Risk Prostate Cancer
Two commonly used assays for the severity of prostate cancer performed equally well in a head-to-head trial.
Source: medscape.com
Page 30 - Ancer Prostate News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ancer Prostate . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ancer Prostate Today - Breaking & Trending Today
Prostate Cancer Survival: Enzalutamide Edges Out Abiraterone
Men with metastatic disease who received enzalutamide demonstrated a small but significant survival benefit. The study was published as a preprint and has not yet been peer reviewed.
Source: medscape.com
AUA 2022: A Report From the Trenches
Colorado urologist Henry M. Rosevear, MD, offers his take on the scientific highlights of this year's annual meeting of the American Urological Association.
Source: medscape.com
Most Men With Low-Risk Prostate Tumors Now Forgoing Treatment
Acceptance of active surveillance for low-risk prostate cancer hit a record high in 2021, although the US still lags internationally, new figures showed.
Source: medscape.com
New Guideline Gives Active Surveillance a Boost
The 2022 guidance for the first time makes active surveillance the recommended treatment for select patients with favorable intermediate-risk Gleason 3+4 prostate cancer.
Source: medscape.com